Zhu, Y., Feng, M., Zhu, D. (2025). Effect of cDC2 licensing by CCL5
            <sup>+</sup>
            Th1 cells following BCL9/BCL9L inhibition on CD8
            <sup>+</sup>
            T cell cross-priming for enhanced anti-tumor responses.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16255